Targeting inflammation to reduce cardiovascular disease risk: a realistic clinical prospect? (2017)

First Author: Welsh P
Attributed to:  In Situ Nanoparticle Assemblies for Healthcare Diagnostics and Therapy funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/bph.13818

PubMed Identifier: 28409825

Publication URI: http://europepmc.org/abstract/MED/28409825

Type: Journal Article/Review

Volume: 174

Parent Publication: British journal of pharmacology

Issue: 22

ISSN: 0007-1188